OMEGA 3 MaxPower - EPA 700mg • DHA 500mg • Vitamin E - 60 caps.

Omega-3 MaxPower

Omega-3 MaxPower ontains 700mg EPA and 500mg DHA per daily dose.

The 3 main omega-3 fatty acids are:

• alpha-linolenic acid (ALA),
• eicosapentaenoic acid (EPA) and
• docosahexaenoic acid (DHA).

These are important in several organic functions including muscle activity, blood coagulation, digestion, fertility, cell division and growth.

DHA is important in brain development and function and ALA is an essential fatty acid. Fish oils provide a variety of supplementary benefits particularly when the ω3: ω6 ratio in the body is almost equal since the Western diet is too rich in ω6 (red meat, eggs, soy, sunflower oil and palm, among others), ω3 is being suggested to balance this ratio (the human organism cannot produce ω3). A 1: 1 ratio of ω3: ω6 is associated with a decreased risk in arterial and lipid health, as well as a lower risk in the accumulation of atheromatous plaque and may also reduce the risk of diabetes (and other metabolic syndromes) as well as various forms of cancer disease (including breast cancer).

EPA is a polyunsaturated fatty acid (PUFA) that acts as a precursor to several eicosanoids such as prostaglandins E3 (PGE3 - which inhibits platelet aggregation), thrombo- xanes A3 (TXA3) and leukotrienes B5 (LTB5).

DHA is an omega-3 polyunsaturated fatty acid that is a primary component of the structure of the human brain, cerebral cortex and retina. It is very important in phospholipids in the brain and retina, additionally, it has been suggested to be relevant in the prevention and treatment of Alzheimer's disease.

DHA is the most abundant omega-3 fatty acid in the brain, as well as the retina, and comprises about 40% of PUFAs in the brain and 60% of retinal PUFAs, with 50% of the weight of the neuronal membrane is composed of DHA.

The control of apoptosis is dependent on phosphatidyl- serine and low levels of DHA decrease cell neuronal PS and increase cell death and it can be said that DHA deficiency is associated with cognitive decline.

Main Indications:

• Hypertriglyceridemia,
• cardiovascu- lar disease and hypertension,
• prevention of obstruction after angioplasty,
• non-alcoholic steatohepatitis (NASH) hepatic steatosis,
• non-alcoholic fatty liver disease (NAFLD).

Other uses:

• In the supporting treatment of endo- metriosis,
• arterial hypertension or renal injury derived from cyclosporines,
• dyspraxia,
• dysmenor- rhea and PMS,
• heart failure and coronary trans- plantation,
• hypercholesterolemia derived from HIV/AIDS or after kidney transplantation,
• IgA nephropathy,
• osteoporosis,
• psoriasis,
• rheumatoid arthritis.

Health claims:

DHA contributes to maintenance of normal brain function;

DHA contributes to the maintenance of normal vision;

EPA and DHA contribute to the normal function of the heart.

The beneficial effect is obtained with a daily intake of 250 mg of EPA and DHA;

Vitamin E contributes to the protection of cells from oxidative stress.